# Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)

> **NCT00731185** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 162 (actual)

## Conditions studied

- Nasal Polyps

## Interventions

- **DRUG:** Mometasone Furoate Nasal Spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00731185
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09-01
- **Primary completion:** 2005-09-01
- **Final completion:** 2005-09-01
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00731185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00731185, "Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00731185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*